Discovery of Zilucoplan: A Peptide Complement C5 Inhibitor in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

Time: 3:00 pm
day: Conference Day 1


• Brief introduction of UCB and origin of zilucoplan

• Examining the biology background and early discovery of zilucoplan – a small, subcutaneously administered, macrocyclic peptide

• Discussing lessons learnt from this clinical success and future directions